Calcium sensors as new therapeutic targets for asthma and chronic obstructive pulmonary disease

Clinical and Experimental Allergy

Volumn 34, Issue 2, 2004, Pages 170-176

  Ten Broeke, R ^a   Blalock, J E ^b   Nijkamp, F P ^a   Folkerts, G ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; SUPEROXIDE;

AIRWAY; ALLERGIC ASTHMA; BIOSENSOR; CELL ADHESION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DEGRANULATION; DRUG TARGETING; EPITHELIUM; HUMAN; LUNG ALVEOLUS MACROPHAGE; MAST CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ANIMALS; ASTHMA; CALCIUM CHANNEL BLOCKERS; CALMODULIN; CARRIER PROTEINS; EPITHELIAL CELLS; GUINEA PIGS; MACROPHAGES; MAST CELLS; MODELS, ANIMAL; OLIGOPEPTIDES; PEPTIDES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 1542285266     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2004.01908.x     Document Type: Review

References (54)

1. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med 2001; 344:350-62.
2. Saetta M. Airway inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160:S17-20.
3. Burney PG, Chinn S, Rona RJ. Has the prevalence of asthma increased in children? Evidence from the national study of health and growth 1973-86. BMJ 1990; 300:1306-10.
4. Lemanske RF Jr, Busse WW. Asthma. JAMA 1997; 278:1855-73.
5. Barnes PJ. Therapeutic strategies for allergic diseases. Nature 1999; 402:B31-8.
6. Stirling RG, Chung KF. Future treatments of allergic diseases and asthma. Br Med Bull 2000; 56:1037-53.
7. Parekh AB, Penner R. Store depletion and calcium influx. Physiol Rev 1997; 77:901-30.
8. Dutta D. Mechanism of store-operated calcium entry. J Biosci 2000; 25:397-404.
9. Dillon J, Woods WT, Guarcello V, LeBoeuf RD, Blalock JE. A peptide mimetic of calcium. Proc Natl Acad Sci USA 1991; 88:9726-9.
10. Villain M, Jackson PL, Manion MK et al. De novo design of peptides targeted to the EF hands of calmodulin. J Biol Chem 2000; 275:2676-85.
11. Manion MK, Su Z, Villain M, Blalock JE. A new type of Ca(2+) channel blocker that targets Ca(2+) sensors and prevents Ca(2+)-mediated apoptosis. FASEB J 2000; 14:1297-306.
12. Manion MK, Villain M, Pan ZG, McDonald JM, Blalock JE. Cellular uptake and in situ binding of a peptide agonist for calmodulin. Biochem Biophys Res Commun 2000; 277:462-9.
13. Djukanovic R, Roche WR, Wilson JW et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990; 142:434-57.
14. Boushey HA, Holtzman MJ, Sheller JR, Nadel JA. Bronchial hyperreactivity. Am Rev Respir Dis 1980; 121:389-413.
15. Folkerts G, Nijkamp FP. Airway epithelium: more than just a barrier. Trends Pharmacol Sci 1998; 19:334-41.
16. Hogman M, Frostell CG, Hedenstrom H, Hedenstierna G. Inhalation of nitric oxide modulates adult human bronchial tone. Am Rev Respir Dis 1993; 148:1474-8.
17. Ricciardolo FL, Geppetti P, Mistretta A et al. Randomised double-blind placebo-controlled study of the effect of inhibition of nitric oxide synthesis in bradykinin-induced asthma. Lancet 1996; 348:374-7.
18. Nijkamp FP, van der Linde HJ, Folkerts G. Nitric oxide synthesis inhibitors induce airway hyperresponsiveness in the guinea pig in vivo and in vitro. Role of the epithelium. Am Rev Respir Dis 1993; 148:727-34.
19. Folkerts G, van der Linde HJ, Nijkamp FP. Virus-induced airway hyperresponsiveness in guinea pigs is related to a deficiency in nitric oxide. J Clin Invest 1995; 95:26-30.
20. Folkerts G, Ten Broeke R, Fischer A, Geppetti P, Nijkamp FP. Nitric oxide control of airway smooth muscle. Eur Respir Rev 2000; 10:249-52.
21. Shaul PW, North AJ, Wu LC et al. Endothelial nitric oxide synthase is expressed in cultured human bronchiolar epithelium. J Clin Invest 1994; 94:2231-6.
22. Liu Q, Gross SS. Binding sites of nitric oxide synthases. Meth Enzymol 1996; 268:311-24.
23. 2+ channels. Science 1995; 270:1502-6.
24. Houtman R, Ten Broeke R, Blalock JE, Villain M, Koster AS, Nijkamp FP. Attenuation of very late antigen-5-mediated adhesion of bone marrow-derived mast cells to fibronectin by peptides with inverted hydropathy to EF-hands. J Immunol 2001; 166:861-7.
25. Siraganian RP. Mast cells and basophils. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: basic principles and clinical correlates. New York: Raven, 1988; 531-54.
26. Schwartz L, Huff T. Biology of mast cells. In: Middleton E, Reed CE, Ellis EF, eds. Allergy: principles and practice. St Louis: Mosby, 1993; 261-76.
27. Hamawy MM, Mergenhagen SE, Siraganian RP. Adhesion molecules as regulators of mast-cell and basophil function. Immunol Today 1994; 15:62-6.
28. Ra C, Yasuda M, Yagita H, Okumura K. Fibronectin receptor integrins are involved in mast cell activation. J Allergy Clin Immunol 1994; 94:625-8.
29. 2+. J Biol Chem 1995; 270:26270-7.
30. Tuckwell DS, Brass A, Humphries MJ. Homology modelling of integrin EF-hands. Evidence for widespread use of a conserved cation-binding site. Biochem J 1992; 285:325-31.
31. 2+ influx through receptor-mediated activation of nonspecific cation channels in mast cells. Proc Natl Acad Sci USA 1993; 90:3068-72.
32. Hoth M, Penner R. Depletion of intracellular calcium stores activates a calcium current in mast cells. Nature 1992; 355:353-6.
33. Bennett JP, Cockcroft S, Gomperts BD. Ionomycin stimulates mast cell histamine secretion by forming a lipid-soluble calcium complex. Nature 1979; 282:851-3.
34. Shapiro SD. The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160:S29-32.
35. Babior BM. Oxygen-dependent microbial killing by phagocytes (first of two parts). N Engl J Med 1978; 298:659-68.
36. Sadeghi-Hashjin G, Folkerts G, Henricks PA et al. Peroxynitrite induces airway hyperresponsiveness in guinea pigs in vitro and in vivo. Am J Respir Crit Care Med 1996; 153:1697-701.
37. Ten Broeke R, Folkerts G, Leusink-Muis T et al. Calcium sensors as new therapeutic targets for airway hyperresponsiveness and asthma. Faseb J 2001; 15:1831-3.
38. Levitan IB. It is calmodulin after all! Mediator of the calcium modulation of multiple ion channels. Neuron 1999; 22:645-8.
39. Su Z, Csutora P, Hunton D, Shoemaker RL, Marchase RB, Blalock JE. A store-operated nonselective cation channel in lymphocytes is activated directly by Ca(2+) influx factor and diacylglycerol. Am J Physiol Cell Physiol 2001; 280:C1284-92.
40. Tanaka T, Ohmura T, Hidaka H. Calmodulin antagonists' binding sites on calmodulin. Pharmacology 1983; 26:249-57.
41. Vandenberg JI, Lummis SC. Ion channels - a plethora of pharmaceutical targets. Trends Pharmacol Sci 2000; 21:409-10.
42. Ten Broeke R, Leusink-Muis A, Hilberdink R et al. Specific modulation of calmodulin activity induces a dramatic production of superoxide by alveolar macrophages. Lab Invest 2004; 84:29-40.
43. 2+ sensors modulate asthmatic symptoms in an allergic model for asthma. Eur J Pharmacol 2003; 476:151-7.
44. Holt PG, Macaubas C, Stumbles PA, Sly PD. The role of allergy in the development of asthma. Nature 1999; 402:B12-7.
45. Muijsers RB, van Ark I, Folkerts G et al. Apocynin and 1400 W prevents airway hyperresponsiveness during allergic reactions in mice. Br J Pharmacol 2001; 134:434-40.
46. Henricks PA, Nijkamp FP. Reactive oxygen species as mediators in asthma. Pulm Pharmacol Ther 2001; 14:409-20.
47. Nilius B, Droogmans G. Ion channels and their functional role in vascular endothelium. Physiol Rev 2001; 81:1415-59.
48. 2+ current impairs agonist-dependent vasorelaxation in TRP4-/- mice. Nat Cell Biol 2001; 3:121-7.
49. Cooper EC, Jan LY. Ion channel genes and human neurological disease: recent progress, prospects, and challenges. Proc Natl Acad Sci USA 1999; 96:4759-66.
50. Hoshino M, Monta S, Iwashita H et al. Increased Expression of the human Ca(2+)-activated Cl(-) channel 1 (CaCCl) gene in the asthmatic airway. Am J Respir Crit Care Med 2002; 165:1132-6.
51. Li SW, Westwick J, Poll CT. Receptor-operated Ca(2+) influx channels in leukocytes: a therapeutic target? Trends Pharmacol Sci 2002; 23:63-70.
52. Fomina AF, Fanger CM, Kozak JA, Cahalan MD. Single channel properties and regulated expression of Ca(2+) release-activated Ca(2+) (CRAC) channels in human T cells. J Cell Biol 2000; 150:1435-44.
53. 2+ stores in human macrophages. J Membr Biol 1995; 146:101-11.
54. von Tscharner V, Prod'hom B, Baggiolini M, Reuter H. Ion channels in human neutrophils activated by a rise in free cytosolic calcium concentration. Nature 1986; 324:369-72.